Home » Topics » BioWorld Science

BioWorld Science
RSS

Pacylex recruits patients with solid malignancies and B-cell lymphoma in phase I trial of PCLX-001

July 23, 2021

South Korea's MDFS clears initiation of phase I study of lenzilumab for COVID-19

July 23, 2021

Function follows form: Predicted protein structures for human proteome now freely accessible

July 23, 2021

Blue Oak Pharmaceuticals describes new antidepressants

July 23, 2021

Memorial Sloan Kettering Cancer Center presents new ULK1 inhibitors

July 23, 2021

Wuhan LL Science and Technology Development divulges P2X4 receptor antagonists

July 23, 2021

Chinese researchers patent coagulation factor XIa inhibitors

July 23, 2021

ECO-RESET study of SER-287 in UC does not meet primary endpoint

July 23, 2021

FDA accepts IND application for ATRS-1902 for adrenal crisis rescue

July 23, 2021

Annexon expands its clinical programs for ANX-009 and ANX-005 in autoimmune disease

July 23, 2021

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...